The methylene blue half-life most websites quote, 5 to 6 hours, comes from older intravenous studies. Newer data put it closer to a day. A 2009 study in 16 healthy volunteers measured a mean plasma half-life of 18.3 hours after an oral dose, and the prescribing information for the injectable hospital product gives about 24 hours. The longer figure is the one to plan around. It decides how long methylene blue stays in your system, how levels build with daily use, and how long the interaction window with serotonergic medicines stays open.
This guide covers what each human study measured, why the numbers disagree, a timeline for a single dose, and what the half-life means for a daily routine with capsules, gummies or drops.
Methylene blue half-life: the short answer
- Current estimate: about 14 to 24 hours. Walter-Sack and colleagues found mean plasma half-lives of 18.5 hours after a 50 mg IV dose and 18.3 hours after a 500 mg oral dose, with 13.6 and 14.7 hours in whole blood. The injectable’s prescribing information says about 24 hours.
- The 5-hour figure is older. Peter and colleagues reported a terminal half-life of 5.25 hours in whole blood after a 100 mg IV dose in 7 volunteers. Later work with more sensitive lab methods picked up a slower tail.
- The peak comes early. After an oral solution, plasma levels peaked at a mean of 2.2 hours.
- Clearing a dose takes days. Five half-lives, the usual point where a single dose is treated as gone, works out to roughly three to five days.
- Daily use builds up to a plateau. Once-daily servings reach a steady level after about three to five days.
What the human studies measured
Four sources supply most of the half-life numbers you will find online. They used different doses, routes and sampling windows, which is why they disagree.
| Source | Who and what dose | What was measured | Half-life reported |
|---|---|---|---|
| Peter et al., 2000, European Journal of Clinical Pharmacology | 7 healthy volunteers, 100 mg IV and 100 mg by mouth | Whole blood (HPLC) | 5.25 hours, terminal, after IV |
| Walter-Sack et al., 2009, European Journal of Clinical Pharmacology | 16 healthy volunteers, 50 mg IV and a 500 mg oral solution, one week apart | Plasma and whole blood | Plasma: 18.5 hours (IV), 18.3 hours (oral). Whole blood: 13.6 hours (IV), 14.7 hours (oral) |
| Repici et al., 2012, Contemporary Clinical Trials | 22 healthy volunteers, 200 mg or 400 mg delayed-release MMX tablets taken with a laxative bowel preparation | Blood | 14 to 27 hours (200 mg), 6 to 26 hours (400 mg) |
| Prescribing information for the injectable (ProvayBlue) | Hospital IV use | Not stated in the elimination section | About 24 hours |
The 2009 study also found that 72.3% (plus or minus 23.9%) of the oral dose reached the bloodstream, far more than earlier work had suggested. None of these studies used 5 or 10 mg supplement servings, and none tracked blood levels over weeks of daily use. The half-life describes how the body clears the molecule, so it is expected to carry over to smaller amounts. That is an inference, though, not a measurement.
Why sources say 5 hours, 18 hours or 24 hours
Longer sampling finds a slower tail
A half-life is estimated from the last part of the concentration curve. If blood draws stop after a few hours, the slow final phase is never seen. Peter and colleagues described a multiphasic curve after IV dosing: a fast early fall as methylene blue leaves the blood for tissues, then a slower decline. Walter-Sack’s team sampled for 24 hours and still found that about a third of the total exposure lay beyond the last blood draw. They recommended 72 to 96 hours of sampling for future studies.
Lab methods became more sensitive
Walter-Sack’s group put much of the gap down to assay sensitivity. Their methods detected total methylene blue in plasma and whole blood far better than earlier ones, and they suspected some older reports had measured only the unbound fraction. Low concentrations late in the curve were simply invisible before.
Plasma versus whole blood matters less than claimed
Some articles say plasma numbers miss most of the compound because it sits inside red blood cells. The data do not support that for a dose taken on its own. In the 2009 study the whole-blood to plasma exposure ratio was 0.98 after IV and 1.07 after oral dosing. The injectable’s prescribing information reports a blood-to-plasma ratio of 5.1 five minutes into an infusion, settling at 0.6 by four hours. Whole blood gave a somewhat shorter half-life in 2009 (about 14 to 15 hours against 18), but the two measures agree far more than the old 5-versus-24 split implies.
Delayed-release tablets stretch the curve
The Repici figures come from MMX tablets built to release methylene blue in the colon for colonoscopy staining. Blood levels kept rising for 12 hours and peaked at a median of 16 hours. While a tablet is still releasing, the measured decline partly reflects slow absorption, not only clearance. Those numbers describe that tablet. They do not describe a capsule, gummy or drop taken with breakfast.
How long methylene blue stays in your system after one dose
Using the 2009 oral figures (a peak at about 2 hours and a plasma half-life of about 18 hours), a single dose follows roughly the path below. This is plain half-life arithmetic from the peak. Real curves fall faster in the first hours as the compound moves into tissue, then more slowly. Individual oral half-lives in that study ranged from under 10 hours to 38 hours, so treat the times as a guide.
| Time after the dose | Share of the peak plasma level left |
|---|---|
| About 2 hours | Peak level |
| About 20 hours | Half |
| About 38 hours | A quarter |
| About 56 hours | An eighth |
| About 74 hours (3 days) | A sixteenth |
| About 92 hours (4 days) | A thirty-second, the usual point where a dose counts as cleared |
Urine color runs on its own clock. In the 2009 study every participant had blue urine for several days after the 500 mg dose, plus blue staining of the mouth and teeth for several hours from the liquid, and all of it had faded within a few days. Supplement servings are 50 to 100 times smaller, so expect less. We have not found a study that timed urine color at 5 or 10 mg.
Where it goes
Methylene blue leaves through the liver and the kidneys. The injectable’s prescribing information says it is extensively metabolized in the liver and substantially excreted by the kidneys, and it advises longer monitoring for people with liver impairment because clearance is delayed. How much turns up in urine varies with dose and study: about 74% of a 10 mg oral dose in a 1972 study summarized by Walter-Sack’s group, 18% after 100 mg by mouth in Peter’s study, and about 40% after 200 mg MMX tablets in Repici’s. Part of what reaches the urine is leucomethylene blue, the colorless reduced form. That is why fading color does not mean the dose has cleared.
If you came here wondering how long an unopened bottle keeps, that is shelf life, a separate question covered in our methylene blue shelf life and storage guide.
What the half-life means for a daily routine
One serving a day is enough
With a half-life of 14 to 24 hours, a morning serving is still partly in circulation the next morning, so splitting a small serving into two adds little. All three NooBlue formats are labeled for one serving a day: one 5 mg methylene blue capsule daily with food, one 10 mg methylene blue gummy, or a measured serving of 1% methylene blue drops at 0.5 mg per drop. Do not exceed the suggested serving. Our guide to how many mg of methylene blue per day covers dose in more detail.
Take it in the morning
A half-life near a day means a morning dose has not been halved by bedtime, which is the main reason to take it early. If sleep feels lighter on days you take it, an earlier serving is the first thing to try. Our article on methylene blue and sleep quality covers what is known.
Levels build for three to five days
Each daily serving lands on what is left of the one before, so levels rise over the first days and then settle. The pharmacology rule of thumb is that steady state arrives after four to five half-lives, which is about three to five days here. On standard one-compartment math, the settled level sits at roughly 1.4 to 2 times the level after a single serving, depending on whether the half-life is 14 or 24 hours. That is a plateau, and it has two practical consequences:
- Judge how a serving suits you after a full week at the same amount, not on day two. For onset timing, see how long methylene blue takes to work.
- Do not raise the amount after a day or two because the effect feels mild. Levels are still climbing.
Missed a serving?
Skip it and take the next one at the usual time. With this half-life a missed day still leaves some methylene blue in circulation, and doubling up only stacks more on a level that is still falling.
Half-life and medicines: how long the interaction window stays open
This is where the half-life matters most. Methylene blue is a potent, reversible inhibitor of monoamine oxidase (MAO). Combined with serotonergic medicines it can cause serotonin syndrome, which can be fatal. The injectable’s prescribing information lists SSRIs, SNRIs, MAOIs, bupropion, buspirone, clomipramine, mirtazapine, linezolid, opioids and dextromethorphan among the medicines to avoid with it.
Because it clears slowly, the risk does not end on the day you stop. The same prescribing information tells patients not to take serotonergic drugs within 72 hours after the last dose. It works the other way too, because some antidepressants linger far longer than methylene blue. Fluoxetine’s own label gives it a half-life of 4 to 6 days with regular use and 4 to 16 days for its active metabolite, and asks for at least 5 weeks after stopping it before an MAOI is started. The same label calls the risk of oral methylene blue with fluoxetine unclear and asks prescribers to watch for serotonin syndrome anyway.
In practice:
- Do not take methylene blue if you take an SSRI, SNRI, MAOI or any other serotonergic medicine.
- If you stopped one recently, ask the prescriber how long it stays active before you start.
- Before a new prescription, surgery or any procedure, tell the doctor or anesthetist that you take methylene blue and when your last serving was. Let them set the gap rather than picking one yourself.
- Agitation, confusion, tremor, muscle twitching, heavy sweating, fever or a racing heart after combining it with any medicine needs urgent medical care.
Our full list of what not to take with methylene blue covers other interactions.
Blue urine, staining and lab tests
- Urine: blue or green urine is expected with every format, capsules, gummies and drops alike. It shows the compound is being excreted.
- Mouth: drops can stain the mouth and tongue for a few hours, so mix them into water or juice. Capsules are swallowed whole. NooBlue gummies don’t leave a blue mouth or tongue.
- Lab tests: because it is excreted in urine and is strongly colored, methylene blue can interfere with urine tests that rely on color indicators. Tell the clinic or lab that you take it. For workplace screening, see our guide on whether methylene blue shows up on a drug test.
Does the format change the half-life?
No. Once methylene blue is absorbed, the body clears it the same way whether it came from a capsule, a gummy or a drop. Format can change how fast it is absorbed and when it peaks, and the delayed-release MMX tablets show that effect at its extreme. For everyday capsules, gummies and drops there is no published head-to-head timing data at supplement servings, so claims that one format peaks a set number of minutes sooner are guesses. Our comparison of methylene blue bioavailability in liquid and capsule form goes further.
The practical differences between NooBlue’s three formats:
- Capsules: a fixed 5 mg serving, one a day with food, 60 per bottle. No taste and nothing to measure.
- Gummies: 10 mg in one chew, with vitamin C, 60 per pack, and no blue mouth.
- Drops: a 1% solution in a 50 mL bottle, measured in 0.5 mg steps. The most flexible option, and the one that can stain.
Who should not take methylene blue
- Anyone taking an SSRI, SNRI, MAOI or any other serotonergic medicine, because of the risk of serotonin syndrome.
- Anyone with G6PD deficiency.
- Anyone who is pregnant or breastfeeding. The injectable’s prescribing information advises stopping breastfeeding for up to 8 days after a dose, another sign of how long the compound lingers.
- Anyone under 18.
Methylene blue can color urine blue or green. Talk to your doctor before use if you take any prescription medicine or have a kidney or liver condition.
NooBlue makes the capsules, gummies and drops linked in this guide. You can read more about NooBlue or compare every format in the NooBlue shop.
Frequently asked questions
What is the half-life of methylene blue?
About 14 to 24 hours on current data. A 2009 study found mean plasma half-lives of 18.5 hours after an IV dose and 18.3 hours after an oral dose, and the injectable’s prescribing information gives about 24 hours. The 5 to 6 hour figure often quoted comes from older studies with shorter sampling and less sensitive lab methods.
How long does methylene blue stay in your system after one dose?
Most of a single dose clears in about three to five days, which is five half-lives. Levels peak around 2 hours after an oral dose and fall to half within about a day. Blue urine lasted several days after a large 500 mg dose in one study.
Does methylene blue build up with daily use?
Yes, up to a plateau. Once-daily servings reach a steady level after about three to five days, at roughly 1.4 to 2 times the level of a single serving on standard half-life math. Give a serving a full week before judging it, and do not exceed the suggested serving.
How much methylene blue per day?
Follow the label of the product you use. NooBlue capsules are one 5 mg capsule daily with food, the gummies are one 10 mg gummy daily, and the 1% drops measure 0.5 mg per drop. Do not exceed the suggested serving. Our daily dose guide goes into more detail.
What should you not mix with methylene blue?
Serotonergic medicines: SSRIs, SNRIs, MAOIs and others such as bupropion, buspirone, mirtazapine, linezolid, opioids and dextromethorphan. The combination can cause serotonin syndrome. Because methylene blue clears slowly, the risk window lasts for days after your last serving, and some antidepressants such as fluoxetine stay active for weeks after they are stopped. Ask your doctor before combining it with any prescription medicine.
Why do I feel weird after taking methylene blue?
Studies at far higher doses reported nausea, headache and blue staining. In the 2009 study the bitter 500 mg liquid caused nausea after 14 of 23 oral doses. If you feel unwell at a supplement serving, stop and talk to your doctor. If you take any medicine and notice agitation, confusion, tremor, twitching, heavy sweating, fever or a racing heart, get urgent medical care, because those can be signs of serotonin syndrome.
Why don’t some doctors recommend methylene blue?
Its established medical uses are in hospital settings, and Harvard Health Publishing points out that a drug working in a specific clinical setting does not mean the general population should take it. The interaction with common antidepressants such as fluoxetine and duloxetine is the other main reason for caution. Tell your doctor you take it, especially before a new prescription or procedure.
Is the half-life different for capsules, gummies and drops?
No. Clearance is the same once it is absorbed. Format can shift how quickly it is absorbed, but there is no published head-to-head timing data for these formats at supplement servings.
Does clear urine mean methylene blue has left my system?
No. Blue or green urine shows it is still being excreted, but part of it leaves as colorless leucomethylene blue, so clear urine does not prove it has cleared.
Sources
- Walter-Sack I, Rengelshausen J, Oberwittler H, et al. High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology. 2009;65(2):179-189. PubMed 18810398
- Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology. 2000;56(3):247-250. PubMed 10952480
- Repici A, Di Stefano AF, Radicioni MM, et al. Methylene blue MMX tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers. Contemporary Clinical Trials. 2012;33(2):260-267. PubMed 22101227
- DiSanto AR, Wagner JG. Pharmacokinetics of highly ionized drugs. II. Methylene blue: absorption, metabolism, and excretion in man and dog after oral administration. Journal of Pharmaceutical Sciences. 1972;61(7):1086-1090. PubMed 5044807
- ProvayBlue (methylene blue) injection, prescribing information. DailyMed
- Prozac (fluoxetine) capsules, prescribing information. DailyMed
- Ostrovsky A, Afzal M. Methylene Blue. StatPearls. NCBI Bookshelf
- Goldman L. What to know about methylene blue. Harvard Health Publishing, 2025. health.harvard.edu
